Please wait

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13D/A 0001104659-13-052713 0001580170 XXXXXXXX LIVE 9 Common Stock, $0.0001 par value per share 03/11/2025 false 0001023024 00182C103 ANI Pharmaceuticals, Inc. 210 Main Street West Baudette MN 56623 Robert A. Graham, MVP Capital (610) 254-2999 259 N. Radnor-Chester Road Suite 130 Radnor PA 19087 0001580170 N Meridian Venture Partners II GP, L.P. ("GP") b OO N DE 0.00 1164381.00 0.00 1164381.00 1164381.00 N 5.4 PN 0001109507 N Meridian Venture Partners II, L.P. b OO N DE 0.00 1164381.00 0.00 1164381.00 1164381.00 N 5.4 PN 0001580169 N Meridian Venture Partners II, Co. b OO N DE 0.00 1164381.00 0.00 1164381.00 1164381.00 N 5.4 CO 0001579672 N Robert E. Brown, Jr. b OO N X1 20189.00 1164381.00 20189.00 1164381.00 1184570.00 N 5.4 IN Common Stock, $0.0001 par value per share ANI Pharmaceuticals, Inc. 210 Main Street West Baudette MN 56623 The shares of Common Stock owned by the Reporting Persons were acquired solely for investment purposes. During the past sixty days the Reporting Persons sold an aggregate of 50,000 shares of Common Stock. On March 10, 2025, the Report Persons sold 2,620 shares at a price of $60.0466 per share. On March 11, 2025, the Reporting Persons sold 47,380 shares at a price of $61.2925 per share. Meridian Venture Partners II GP, L.P. ("GP") /s/ Robert E. Brown, Jr. Robert E. Brown, Jr. 03/13/2025 Meridian Venture Partners II, L.P. /s/ Robert E. Brown, Jr. Robert E. Brown, Jr. 03/13/2025 Meridian Venture Partners II, Co. /s/ Robert E. Brown, Jr. Robert E. Brown, Jr. 03/13/2025 Robert E. Brown, Jr. /s/ Robert E. Brown, Jr. Robert E. Brown, Jr. 03/13/2025